SL-172154 is a bi-functional fusion protein targeting CD47 on tumor cells and CD40 on immune cells. SL-172154 is being studied for use in different cancer indications.
You can give us a call at (888) 828-2206 or create your account to add this treatment to your list of favorites. We'll send you alerts when this treatment is updated.